Popescu Irinel, Ionescu Mihnea, Braşoveanu Vladislav, Hrehoreţ Doina, Copca Narcis, Lupaşcu Cristian, Botea Florin, Dorobanţu Bogdan, Alexandrescu Sorin, Grigorie Mihai, Matei Emil, Zamfir Radu, Lungu Vasile, Tomescu Dana, Droc Gabriela, Ungureanu Daniela, Fota Ruxandra, Manga Graţiela, Popescu Mihai, Popa Laura, Gheorghe Liana, Iacob Speranţa, Pietrăreanu Corina, Mihailă Mariana, Mic Laurenţiu, Constantinescu Sanda, Gheorghe Cristian, Cotruta Bogdan, Lupescu Ioana, Grasu Mugur, Boroş Mirela, Dumitru Radu, Toma Mihai, Paslaru Liliana, Vlad Laura, Constantinescu Ileana, Dima Ileana, Herlea Vlad, Becheanu Gabriel, Pecheanu Cătălin, Sasalovici Daniela
Chirurgia (Bucur). 2017 May-Jun;112(3):229-243. doi: 10.21614/chirurgia.112.3.229.
Liver transplantation (LT) has become an established treatment for end-stage liver disease, with more than 20.000 procedures yearly worldwide. The aim of this study was to analyze the results of Romanian National Program of LT. Between April 2000 and April 2017, 817 pts received 852 LTs in Romania. Male/female ratio was 487/330, while adult/pediatric ratio was 753/64, with a mean age of 46 years (median 50 yrs; range 7 months - 68 yrs). Main LT indications were HBV cirrhosis (230 pts; 28.2%), HCC (173 pts; 21.2%), and HCV cirrhosis (137 pts; 16.8%). Waiting time and indications for LT, patient and donor demographics, graft features, surgical procedures, and short and long-term outcomes were analyzed. DDLT was performed in 682 pts (83.9%): whole LT in 662 pts (81%), split LT in 16 pts (2.3%), reduced LT in 2 pts (0.2%), and domino LT in 1 pts (0.1%). LDLT was performed in 135 pts (16.5%): right hemiliver in 93 pts (11.4%), left lateral section in 28 pts (3.4%), left hemiliver in 8 pts (1%), left hemiliver with segment 1 in 4 pts (0.5%), and dual graft LDLT in 2 pts (0.2%). Overall major morbidity rate was 31.4% (268 pts), while perioperative mortality was 7.9% (65 pts). Retransplantation rate was 4.3% (35 pts): 27 whole LTs, 3 reduced LTs, 3 split LTs, and 2 LDLT. Long-term overall 1-, 3-, and 5-year estimated survival rates for patients were 87.9%, 81.5%, and 79.1%, respectively. One-, 3-, and 5-year overall mortality on waiting list also decreased significantly over time from 31.4%, 54.1% and 63.5%, to 4.4%, 13.9% and 23.6%, respectively. The Romanian National program for liver transplantation addresses all causes of acute and chronic liver failure or liver tumors in adults and children, using all surgical techniques, with good long-term outcome. The program constantly evolved over time, leading to decreased mortality rate on the waiting list.
肝移植(LT)已成为终末期肝病的既定治疗方法,全球每年有超过20000例手术。本研究的目的是分析罗马尼亚国家肝移植项目的结果。2000年4月至2017年4月期间,罗马尼亚817例患者接受了852例肝移植。男女比例为487/330,成人/儿童比例为753/64,平均年龄46岁(中位数50岁;范围7个月至68岁)。主要肝移植适应证为乙肝肝硬化(230例;28.2%)、肝癌(173例;21.2%)和丙肝肝硬化(137例;16.8%)。分析了等待时间和肝移植适应证、患者和供体人口统计学、移植物特征、手术程序以及短期和长期结果。682例患者(83.9%)进行了尸体供肝肝移植(DDLT):662例患者(81%)进行了全肝移植,16例患者(2.3%)进行了劈离式肝移植,2例患者(0.2%)进行了减体积肝移植,1例患者(0.1%)进行了多米诺肝移植。135例患者(16.5%)进行了活体供肝肝移植(LDLT):93例患者(11.4%)进行了右半肝移植,28例患者(3.4%)进行了左外叶移植,8例患者(1%)进行了左半肝移植,4例患者(0.5%)进行了含第1肝段的左半肝移植,2例患者(0.2%)进行了双供体活体肝移植。总体主要发病率为31.4%(268例),围手术期死亡率为7.9%(65例)。再次移植率为4.3%(35例):27例全肝移植,3例减体积肝移植,3例劈离式肝移植,2例活体供肝肝移植。患者的长期总体1年、3年和5年估计生存率分别为87.9%、81.5%和79.1%。等待名单上的1年、3年和5年总体死亡率也随着时间的推移显著下降,分别从31.4%、54.1%和63.5%降至4.4%、13.9%和23.6%。罗马尼亚国家肝移植项目采用所有手术技术,针对成人和儿童急性和慢性肝衰竭或肝肿瘤的所有病因,长期效果良好。该项目随着时间的推移不断发展,导致等待名单上的死亡率下降。